Gametocyte Clearance in Uncomplicated and Severe Plasmodium falciparum Malaria afterArtesunate-Mefloquine Treatment in Thailand
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Artemisinin-based combination therapy (ACT) is currently promoted as a strategy for treating both uncomplicated and severe falciparum malaria, targeting asexual blood-stage Plasmodium falciparum parasites. However, the effect of ACT on sexual-stage parasites remains controversial. To determine the clearance of sexual-stage P. falciparum parasites from 342 uncomplicated, and 217 severe, adult malaria cases, we reviewed and followed peripheral blood sexualstage parasites for 4 wk after starting ACT. All patients presented with both asexual and sexual stage parasites on admission, and were treated with artesunate-mefloquine as the standard regimen. The results showed that all patients were asymptomatic and negative for asexual forms before discharge from hospital. The percentages of uncomplicated malaria patients positive for gametocytes on days 3, 7, 14, 21, and 28 were 41.5, 13.1, 3.8, 2.0, and 2.0%, while the percentages of gametocyte positive severe malaria patients on days 3, 7, 14, 21, and 28 were 33.6, 8.2, 2.7, 0.9, and 0.9%, respectively. Although all patients were negative for asexual parasites by day 7 after completion of the artesunate-mefloquine course, gametocytemia persisted in some patients. Thus, a gametocytocidal drug, e.g., primaquine, may be useful in combination with an artesunate-mefloquine regimen to clear gametocytes, so blocking transmission more effectively than artesunate alone, in malaria transmission areas.
Abstract
Artemisinin-based combination therapy (ACT) is currently promoted as a strategy for treating both uncomplicated and severe falciparum malaria, targeting asexual blood-stage Plasmodium falciparum parasites. However, the effect of ACT on sexual-stage parasites remains controversial. To determine the clearance of sexual-stage P. falciparum parasites from 342 uncomplicated, and 217 severe, adult malaria cases, we reviewed and followed peripheral blood sexualstage parasites for 4 wk after starting ACT. All patients presented with both asexual and sexual stage parasites on admission, and were treated with artesunate-mefloquine as the standard regimen. The results showed that all patients were asymptomatic and negative for asexual forms before discharge from hospital. The percentages of uncomplicated malaria patients positive for gametocytes on days 3, 7, 14, 21, and 28 were 41.5, 13.1, 3.8, 2.0, and 2.0%, while the percentages of gametocyte positive severe malaria patients on days 3, 7, 14, 21, and 28 were 33.6, 8.2, 2.7, 0.9, and 0.9%, respectively. Although all patients were negative for asexual parasites by day 7 after completion of the artesunate-mefloquine course, gametocytemia persisted in some patients. Thus, a gametocytocidal drug, e.g., primaquine, may be useful in combination with an artesunate-mefloquine regimen to clear gametocytes, so blocking transmission more effectively than artesunate alone, in malaria transmission areas.
참고문헌 (15)
- Targett G., "Artesunate reduces but does not prevent post treatment transmission of Plasmodium falciparum to Anopheles gambiae", JOURNAL OF INFECTIOUS DISEASES, 183, pp.1254~1259 (2001)
- Hallett R. L., "Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes", Antimicrobial Agents and Chemotherapy, 48, pp.3940~3943 (2004)
- Nacher M., "Comparison of artesunate and chloroquine activities against Plasmodium vivax gametocytes", Antimicrobial Agents and Chemotherapy, 48, pp.2751~2752 (2004)
- Doherty J. F., "A randomized safety and tolerability trial of artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone for treatment of uncomplicated malaria in Gambian children", Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, pp.543~546 (1999)
- Drakeley C. J., "Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes", TROPICAL MEDICINE & INTERNATIONAL HEALTH, 9, pp.53~61 (2004)
- Sutherland C. J., "Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether", PLOS MEDICINE, 2, pp.e92~ (2005)
- World Health Organization, "Severe falciparum malaria", Transactions of the Royal Society of Tropical Medicine and Hygiene, 94(S1), pp.1~90 (2000)
- World Health Organization, "Guidelines for the treatment of malaria. 1st ed", pp.133~143 (2006), WHO
- Silachamroon U., "An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria", The Southeast Asian journal of tropical medicine and public health, 36, pp.591~596 (2005)
- Piyaphanee W., "Emergence and clearance of gametocytes in uncomplicated Plasmodium falciparum malaria", AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 74, pp.432~435 (2006)
- Tangpukdee N., "Efficacy of artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand", The Southeast Asian journal of tropical medicine and public health, 39, pp.1~8 (2008)
- Bousema J. T., "Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum", JOURNAL OF INFECTIOUS DISEASES, 193, pp.1151~1159 (2006)
- Sowunmi A., "Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in Southwestern Nigeria", AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 77, pp.235~241 (2007)
- van den Broek I., "Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo", MALARIA JOURNAL, 5, pp.113~ (2006)
- Ali E., "Increased density but not prevalence of gametocytes following drug treatment of Plasmodium falciparum", Transactions of the Royal Society of Tropical Medicine and Hygiene, 100, pp.176~183 (2006)